APA aipamena

Wu, C., Lusvarghi, S., Tseng, P., Hsiao, S., Huang, Y., Hung, T., & Ambudkar, S. V. (2020). MY-5445, a phosphodiesterase type 5 inhibitor, resensitizes ABCG2-overexpressing multidrug-resistant cancer cells to cytotoxic anticancer drugs. Am J Cancer Res.

Chicago Style aipamena

Wu, Chung-Pu, Sabrina Lusvarghi, Pin-Jung Tseng, Sung-Han Hsiao, Yang-Hui Huang, Tai-Ho Hung, and Suresh V. Ambudkar. "MY-5445, a Phosphodiesterase Type 5 Inhibitor, Resensitizes ABCG2-overexpressing Multidrug-resistant Cancer Cells to Cytotoxic Anticancer Drugs." Am J Cancer Res 2020.

MLA aipamena

Wu, Chung-Pu, et al. "MY-5445, a Phosphodiesterase Type 5 Inhibitor, Resensitizes ABCG2-overexpressing Multidrug-resistant Cancer Cells to Cytotoxic Anticancer Drugs." Am J Cancer Res 2020.